Clinical Trial Update: A Pilot Study of 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe Imaging in Men With Prostate Cancer Undergoing Prostatectomy

View source ↗

Summary

A pilot imaging trial using 123I-MIP-1072 with SPECT/CT for prostate cancer undergoing prostatectomy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 123I MIP 1072

Snippet

Sponsor: Molecular Insight Pharmaceuticals, Inc. | Conditions: Prostate Cancer | Status: WITHDRAWN